Regulation of Peroxisome Proliferator Activated Receptor‐γ in Rat Pituitary

Peroxisome proliferator activated‐receptor γ (PPARγ) is a member of the nuclear receptor superfamily and, in addition to its relation with obesity and insulin sensitivity, it has recently been localized in human and mice pituitary, indicating a functional significance of PPARγ in adenopituitary tumours. In the present study, we localized the PPARγ mRNA and protein in different cell types of rat pituitary. Moreover, using the real‐time polymerase chain reaction, we assessed the mRNA expression of PPARγ in different physiological and pathological settings known to be associated with alterations in anterior pituitary cell proliferation and/or function. Our experiments have shown that PPARγ mRNA levels were repressed by oestrogen through an oestrogen receptor‐α effect. However, PPARγ protein levels were only modified in males but not in females. On the other hand, PPARγ mRNA expression was increased in dwarf rats in comparison with Lewis rats. Finally, nutritional, thyroid status or pregnancy did not change PPARγ expression. Taken together, we provide new data regarding the regulation of pituitary PPARγ mRNA by hormonal and metabolic status.

[1]  M. Fu,et al.  Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity , 2004 .

[2]  J. Toppari,et al.  Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors , 2004, Journal of Cell Science.

[3]  J. Sánchez-Criado,et al.  Regulation of Estrogen Receptor (ER) Isoform Messenger RNA Expression by Different ER Ligands in Female Rat Pituitary1 , 2004, Biology of reproduction.

[4]  S. Melmed Mechanisms for pituitary tumorigenesis: the plastic pituitary. , 2003, The Journal of clinical investigation.

[5]  F. Casanueva,et al.  Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland. , 2003, Endocrinology.

[6]  F. Casanueva,et al.  Resistin is expressed in different rat tissues and is regulated in a tissue‐ and gender‐specific manner , 2003, FEBS letters.

[7]  S. Melmed,et al.  PPAR-γ receptor ligands: novel therapy for pituitary adenomas , 2003 .

[8]  I. Robinson,et al.  Increased lactotrophs despite decreased somatotrophs in the dwarf (dw/dw) rat: a defect in the regulation of lactotroph/somatotroph cell fate? , 2002, The Journal of endocrinology.

[9]  S. Melmed,et al.  Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas , 2002, Nature Medicine.

[10]  W. Wahli,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding , 2022 .

[11]  L. Seoane,et al.  Prepro-orexin mRNA levels in the rat hypothalamus, and orexin receptors mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status , 2001, Neuroscience Letters.

[12]  T. Willson,et al.  The PPARs: from orphan receptors to drug discovery. , 2000, Journal of medicinal chemistry.

[13]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[14]  Margaret S. Wu,et al.  Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects* , 1999, The Journal of Biological Chemistry.

[15]  J. Veldhuis,et al.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. , 1998, Endocrine reviews.

[16]  B. Spiegelman,et al.  Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity. , 1997, European journal of medical research.

[17]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[18]  L. Frohman,et al.  Impaired growth hormone-releasing hormone signal transduction in the dwarf (dw) rat is independent of a generalized defect in the stimulatory G-protein, Gs alpha. , 1993, Endocrinology.

[19]  L. Frohman,et al.  Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. , 1993, Endocrinology.

[20]  B. Katzenellenbogen,et al.  Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. , 1993, Endocrinology.

[21]  B. Scheithauer,et al.  The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. , 1990, Mayo Clinic proceedings.

[22]  I. Robinson,et al.  Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin. , 1990, The Journal of endocrinology.

[23]  B. Bloch,et al.  Growth hormone-deficient dwarfism in the rat: a new mutation. , 1988, The Journal of endocrinology.

[24]  S. Melmed,et al.  PPAR-gamma receptor ligands: novel therapy for pituitary adenomas. , 2003, The Journal of clinical investigation.

[25]  F. Casanueva,et al.  Cellular distribution and regulation of ghrelin mRNA in the rat pituitary gland , 2003 .

[26]  B. Spiegelman,et al.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.

[27]  J. Stern,et al.  Animal models of obesity: genetic aspects. , 1991, Annual review of nutrition.

[28]  J. Blume,et al.  Estrogen regulation of gene transcription and mRNA stability. , 1989, Recent progress in hormone research.